Skip to content

A Study Comparing Mundi Kwatham with and without Navya Tharapy of Vansh mool and Kanpur for Migraine Treatment.

A COMPARATIVE PHARMACO-CLINICAL STUDY ON MUNDI KWATHAM (Sphaeranthus indicus Linn.) WITH AND WITHOUT AVAPIDAN NASYA OF VANSH MOOL (Bamboosa arundinacea Willd.) & KARPURA (Cinnamomum camphora) IN THE MANAGEMENT OF ARDHAVABHEDAKAM (MIGRAINE). - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111915
Enrollment
60
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G891- Acute pain, not elsewhere classified

Interventions

None listed

Sponsors

Govt Auto Dhanwantari Ayurvedic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient satisfying the diagnostic criteria accepted by international head ache society for migraine Common migraine without aura. Patients of age group between 15 to 60 years Patients of either sex

Exclusion criteria

Exclusion criteria: Patients having classical migraine with aura, vertebro basilar migraine, post traumatic migraine, Complicated migraine, hemiplegic migraine. Patients having history of epilepsy, Stroke and Head injury. Malignancy, Brain tumor Patients aged below 15 years and above 60 years Pregnant and lactating ladies Patients with systemic disease like diabetes Mellitus, Hyper Tension, Chronic renal or liver disease, HIV, T.B etc.

Design outcomes

Primary

MeasureTime frame
To reduce Severity of Pain, Photophobia/Prakashasahatha Duration of Pain, Phonophobia/Sabdasahatha, Frequency of Attack, Vomiting/Chhardi, Vertigo/BhramaTimepoint: The outcome will be assessed after 30 days

Secondary

MeasureTime frame
Effective management of Ardhavbhedakam (Migraine) by relieving the symptoms like Severity of Pain, Photophobia/Prakashasahatha Duration of Pain, Phonophobia/Sabdasahatha, Frequency of Attack, Vomiting/Chhardi, Vertigo/BhramaTimepoint: The outcome will be assessed after 30 days

Countries

India

Contacts

Public ContactDr Sunita D Ram

Govt. Dhanwantri Ayurvedic Medical College Ujjain

drsunitadram72@gmail.com9685327279

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026